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F
rom Impressionism and Pop Art to phosphorylation
sites and interacting atom pairs, the realm of curation
has been expanded. The recent growth of
bioinformatics, driven by exponentially growing data,
advanced computing techniques, and increased funding from
private and governmental organizations, has created the need
for novel strategies to adequately capture, store, and analyze
the multitude of data present in the scientiﬁc literature. To
meet this challenge, the number and scope of scientiﬁc
databases has soared in recent years, creating a new
profession, the biocurator. Indeed, the present emphasis on
expanding computational resources, capable of managing
and analyzing complex biological data, presents an ever-
growing demand for biocurators capable of interpreting the
increasingly complex scientiﬁc literature and extracting
relevant data in an efﬁcient, yet consistent, manner.
The Immune Epitope Database and Analysis Resource
(IEDB) at http://www.immuneepitope.org [1,2] was established
to capture, house, and analyze complex immune-epitope–
related data extracted from the scientiﬁc literature by a team
of specialized biocurators. Our experiences as IEDB
biocurators are presented here to provide insight into the
role of the biocurator and the challenges of literature-based
curation of complex scientiﬁc data.
The goal of the IEDB is to provide the scientiﬁc community
with open access to concise and comprehensive
immunological data and analysis resources in a previously
unavailable format. The IEDB catalogues epitope sequences
and structures; however, we further expand the magnitude of
accessible information by including data regarding the
immunological contexts in which the epitopes are deﬁned
and assayed (MHC binding, T cell, B cell, or MHC ligand
elution). This affords the user the ability to generate reﬁned
queries to selectively access data of interest. To achieve this
utility, our biocurators manually capture immunological data
from the published literature at an unprecedented level of
detail that includes data ﬁelds ranging from simple concepts
such as the antigen, immunogen, and assay type to more
advanced ﬁelds such as the TCR chain types, TCR residues
interacting with the epitope MHC complex, and detailed
information regarding carriers or vectors. Therefore,
interpretation of the highly detailed and complex
experimental data included in the IEDB requires a team of
graduate-level biocurators with both theoretical and research
experience in immunology and related ﬁelds. The IEDB
currently employs eight full-time and two part-time scientists
as biocurators.
Although IEDB biocurator duties are diverse, their primary
role is curation of data from the published literature. The
initial curation of a typical manuscript requires
approximately four hours, reﬂective of the high degree of
detail that is captured from each reference (published
article). While the granularity of the curated data
distinguishes the IEDB as a novel resource, it also necessitates
speciﬁc curation guidelines and a comprehensive review
process that ensures accuracy and precision of each curation
prior to its release into the public database. The IEDB
biocurator plays a key role both in the formulation of these
guidelines and in the review process.
The nature of the data relevant to the IEDB required us to
establish well-deﬁned curation guidelines to promote
consistency and to clearly delineate objective representation of
the data from subjective interpretation of the data. In
conjunction with a group of prominent senior
immunologists, known as the Epitope Council (EC), the
biocurators continuously develop the Curation Manual. This
manual provides precise instructions regarding the strategies
and procedures for capturing, annotating, and introducing
complex and detailed data from the literature into the IEDB.
The Curation Manual is used to ensure validity,
standardization, and the efﬁciency of the curation process,
and coevolves with the database as we continually encounter
circumstances that require new guidelines to be established.
The current IEDB Curation Manual (version 14) is publicly
available through the IEDB website.
Despite the use of our extensive Curation Manual, there are
difﬁcult situations that inherently arise during curation. We
often encounter inconsistent terminologies in the literature
that present formidable challenges to our consistent
interpretation of the data. Scientists frequently use highly
diverse and controversial nomenclature, for example, in the
naming of MHC molecules. The methods used to perform an
experiment may be somewhat obscure or contradictory. The
conclusions drawn by the authors may be difﬁcult to
represent based upon the limitations of the database ﬁelds
and our curation guidelines. Newly created assay types may
require interpretation and assignment to a particular assay
group. Thus, valuable meetings involving the curation team
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curation and to review speciﬁc references. While every effort
is made to address such problems using our established
guidelines, novel challenges are often dealt with on a
reference-by-reference basis. The solution is then translated
into a generalized guideline that can be consistently applied
to similar occurrences in the future.
The level of detail and precision that we aspire to capture
can lead to disagreements over the speciﬁcs. Issues as simple
as assigning an effector cell type, the semantics used to
describe an assay type, or even the qualitative result can lead
to a great deal of discussion. Many times authors may discuss
conclusions or assumptions that are not depicted in the
ﬁgures. As the goal of the IEDB is to present as much
information as possible without subjective interpretation, we
can never presume any information, but rather we must try to
capture the data exactly as presented in the reference, while
maintaining the conclusions of the reference in a uniform
manner. For example, if all experiments are performed with a
whole cell population, but the authors attribute the response
to a particular cell type without any evidence, we must
capture the effector cells as the entire population.
To further ensure accuracy, we often contact the authors of
papers to clarify details of the experimental procedures, to
obtain epitope sequence data, or to request speciﬁc
information regarding the source of the epitope. For
example, we strive to link each curated epitope to an
appropriate GenBank or SwissProt database entry in order to
provide the user with the exact source of the published
epitope. Often, this valuable link cannot be assigned due to
an amino acid discrepancy between the sequence provided in
the manuscript and the sequences present in GenBank or
SwissProt. In these cases, we attempt to resolve this issue by
contacting the author or searching the citations in the
manuscript. In our experience, these efforts result in
successful contact and clariﬁcation in approximately 50% of
cases and serve to enhance a signiﬁcant amount of our data.
Additionally, authors may provide feedback, corrections, or
clariﬁcation to any data present within the IEDB through
links provided on the Web site. In the event of a
disagreement, the biocurator would work with the author to
rectify the data representation. However, to this date, no such
conﬂict has arisen.
For further quality assurance, we have implemented a two-
tiered review system, consisting of an initial phase of peer
review, followed by detailed review by the EC. Senior
biocurators typically spend 25%–50% of their time peer-
reviewing the curations of other biocurators. This is an
interactive process, in which we discuss the curation and the
reviewer recommends modiﬁcations. The subsequent EC
review process not only adds another layer of scrutiny, but
also provides an opportunity to evaluate our curation
guidelines and the scope of the database in light of speciﬁc
references. This process has proven to enhance the quality of
the curation that ultimately becomes public.
In addition to curation, IEDB biocurators typically devote
approximately 25% of their time to non-curation efforts
relating to the IEDB. This enables the biocurator to become
involved in a variety of projects. As a novel database, the
design and implementation of the IEDB offers many
challenges that require a creative approach. Since the
database has been public for less than six months, biocurators
at the IEDB have the opportunity to be involved with
developmental aspects of the project such as software
programming, tool development, and database design, in
addition to curation. For example, several biocurators are
currently enhancing the IEDB ontology which will be made
publicly available for use by the scientiﬁc community or
relevant databases. Furthermore, certain biocurators are
focusing on becoming experts in analyzing the data they
curate. For example, all inﬂuenza epitopes present in the
IEDB were recently analyzed for sequence conservancy
between the different strains (unpublished data: Bui HH,
Peters B, Assarsson E, Mbawuike I, Sette A, Antibody and T
cell epitopes of Inﬂuenza A virus—Knowledge and
opportunities).
Communication with authors and end-users is a critical
skill for the IEDB biocurator for the purposes of curation,
database development, and for community outreach efforts
to raise public awareness about the IEDB. We often consult
with outside scientists for subject-matter expertise. For
example, because the IEDB staff is composed of scientists
with predominantly T cell expertise, we have sought external
B cell experts for input on database design and the
development of related curation rules. IEDB biocurators also
act as ambassadors for the database, both to raise community
awareness and to collect positive and constructive feedback.
We must be aware of the needs of the IEDB end-user to
productively enhance the curation guidelines, database
structure, and ontology. We attend national and
international conferences to promote and discuss the
database with both end-users and contributors.
Representatives from the IEDB attended the First
International Biocurator Meeting in December 2005 where
curation teams representing 106 databases gathered to
exchange information and ideas. Additionally, the IEDB was
presented at both the 2006 Keystone Symposium and The
Annual Meeting of American Association of Immunologists
(2006).
The biocurator’s role is dynamic and evolves in parallel
with developments in bioinformatics, bridging the gap
between knowledge and its accessibility. Regardless of the
source and subject of the data, the biocurator accumulates
disparate, but relevant data into one centralized location
where it is made more accessible to researchers. The
organized and analyzed data are thus made available for
retrieval, analysis, and download by the end-user in an
enhanced format, providing an added dimension of utility
that would not otherwise be present.
As biocurators, we must be able to understand scientiﬁc
data and to incorporate the curation guidelines in a way that
maintains the integrity of both. Open communication
between the scientists and the biocurators may foster a better
understanding of the difﬁculties encountered by the
biocurator and facilitate a more standardized approach to
data representation in the literature. The growing use of and
contribution to various high-impact databases underscores
the need to establish or reﬁne standardized biological
vocabularies and deﬁnitions. With more experienced
scientists as biocurators, an accurate and controlled
vocabulary among database users and contributors can be
developed and promoted. The use of a shared vocabulary
increases curation speed, data consistency, and serves to
connect the information contained in multiple databases.
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efﬁciency of data curation and exchange. Such reform should
eventually diffuse throughout the scientiﬁc community and
be reﬂected in the literature.
New methodologies allow scientiﬁc data to grow at an
exponential pace, creating a steady demand for reliable,
consistent, and accurate databases. As bioinformatics
resources continue to grow, so will the role of the biocurator
in their development. The expansion of bioinformatics and
its applications paints a promising future for the
biocurator. &
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